Arturo Loaiza-Bonilla, MD, MSEd, FACP, Author at Grand Rounds in Urology

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Cancer Treatment Centers of America

Philadelphia, Pennsylvania

Dr. Loaiza-Bonilla is Vice Chairman of the Department of Medical Oncology at Cancer Treatment Centers of America (CTCA) in Philadelphia, Pennsylvania. Dr. Loaiza-Bonilla is dedicated to comprehensive care for patients suffering from gastrointestinal malignancies, such as colon, esophagus, gastric, liver, pancreas, and neuroendocrine tumors. Dr. Loaiza-Bonilla earned a medical degree from the Universidad Nacional de Colombia in Bogotá, Colombia. Following medical school, he completed an Internship and Residency in Internal Medicine at Harbor Hospital Center in Baltimore, Maryland. Dr. Loaiza-Bonilla also completed a Fellowship in Hematology and Oncology at the University of Miami, Miller School of Medicine. Prior to joining CTCA, Dr. Loaiza-Bonilla was an Assistant Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania. During this time, he completed his master’s degree in medical education at the same university. Dr. Loaiza-Bonilla has been published in several medical journals and oncology publications. He is also a reviewer and counselor for several journals, special interest groups, panels and academic competitions. He has also served as principal investigator and co-investigator for many large oncology clinical trials. Dr. Loaiza-Bonilla has been a member and held leadership positions for several medical organizations. These include the Pennsylvania Society of Oncology and Hematology, the American Society of Hematology, the American Society of Clinical Oncology, and the American Association of Cancer Research.

Disclosures:

Articles by Arturo Loaiza-Bonilla, MD, MSEd, FACP

NET Background and Therapy

Posted by Arturo Loaiza-Bonilla, MD, MSEd, FACP | Aug 2018

Arturo Loaiza-Bonilla, MD, MSEd, FACP, explains the basic scientific concepts behind neuroendocrine tumors (NETs), as well as classifying and staging these cancers. He then discusses the rationale behind targeting somatostatin receptors in NETs, therapy options, and future research in this setting.

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Cancer Treatment Centers of America

Philadelphia, Pennsylvania

Articles by Arturo Loaiza-Bonilla, MD, MSEd, FACP

NET Background and Therapy

Join the GRU Community

You have Successfully Subscribed!

CARDEN JENNINGS PUBLISHING CO., LTD.

INFO

Your GRU

– Account Dashboard
– Your Courses

Recent Updates

Exercise & Wellness

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Cancer Treatment Centers of America

Philadelphia, Pennsylvania

Articles by Arturo Loaiza-Bonilla, MD, MSEd, FACP

NET Background and Therapy

Join the GRU Community

You have Successfully Subscribed!

CARDEN JENNINGS PUBLISHING CO., LTD.

INFO

Your GRU

– Account Dashboard – Your Courses

Recent Updates

Exercise & Wellness

– Account Dashboard
– Your Courses